πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 94 of 200 Β· A–Z by INN

  1. icotinib

    NMPA: clinical trials

  2. icotrokinra hydrochloride

    ICOTYDE

    ORAL FDA: approved

  3. icp-

    NMPA: clinical trials

  4. idarubicin

    ZAVEDOS SOLUTION Pfizer Australia Pty Ltd

    TGA: approved

  5. idarubicin hydrochloride

    IDARUBICIN HYDROCHLORIDE Teva Pharma GmbH

    INTRAVENOUS FDA: approved

  6. idarucizumab

    PRAXBIND

    INJECTION FDA: approved Β· EMA: approved Β· PMDA: approved

    V03AB
  7. idebenone

    RAXONE

    EMA: approved

    N06BX13
  8. idecabtagene vicleucel

    ABECMA

    EMA: approved

    L01
  9. idelalisib

    ZYDELIG Gilead Sciences Pty Limited

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    L01XX47
  10. idoxuridine

    STOXIL

    OPHTHALMIC FDA: approved

  11. idursulfase

    ELAPRASE Takeda

    IV (INFUSION) FDA: approved Β· EMA: approved

    A16AB09
  12. ifosfamide

    HOLOXAN BAXTER HEALTHCARE PTY LTD

    INJECTION FDA: approved Β· TGA: approved

  13. igev

    NMPA: clinical trials

  14. igovomab

    INDIMACIS 125

    EMA: withdrawn

    V09IB03
  15. iloperidone

    FANAPTUM Vanda Pharmaceuticals Netherlands B.V.

    ORAL FDA: approved Β· EMA: unknown

    N05AX14
  16. iloprost

    VENTAVIS Bayer Australia Ltd

    INHALATION FDA: approved Β· EMA: approved Β· TGA: approved

    B01AC11
  17. imatinib

    ARX-IMATINIB Alphapharm Pty Ltd

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01EA01
  18. imatinib mesylate

    IMATINIB MESYLATE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  19. imciromab pentetate

    MYOSCINT

    FDA: approved

  20. imeglimin hydrochloride

    TWYMEEG

    PMDA: approved

  21. imetelstat

    RYTELO

    EMA: approved

    L01XX80
  22. imetelstat sodium

    RYTELO

    INTRAVENOUS FDA: approved

  23. imiglucerase

    CEREZYME

    INJECTION FDA: approved Β· EMA: approved

    A16AB02
  24. imipenem

    RECARBRIO

    EMA: approved

    J01DH56

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources